Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Practice Management & Services
inventivhealth.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$475M

Valuation

$0000 

About inVentiv Health

inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of therapies to market. The Company's combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services, processes and integrated solutions designed to improve client performance.

inVentiv Health Headquarter Location

1 Van de Graaff Drive

Burlington, Massachusetts, 01803,

United States

800-416-0555

Latest inVentiv Health News

The Top 100 Healthcare Technology Companies of 2021

Aug 23, 2021

. This year’s awardees comprise a broad range of companies from well-known names like Johnson & Johnson, 3M Health Care, and Illumina to relatively newer but rapidly growing enterprises such as GRAIL, Capsule, and DNA Script. The diverse range of sophisticated products and services offered through these companies — from digital pharmacies to holistic patient care and AI-powered robotics to digital healthcare payments — have not only led to the modernization of the healthcare sector but also to a brighter future where healthcare is democratized for all. Advancements in healthcare, whether through data and communications, research and clinical trials, medical devices or consumer offerings, have also helped to create an environment where more promising care alternatives are possible. The pioneering companies selected for this year’s list have one thing in common: they are revolutionizing the way we live, and the way we navigate one of the most important factors for us all: our health. The following awardees were nominated and selected based on a thorough evaluation process. Among the key criteria considered were product or service quality, customer adoption, management team caliber, organizational effectiveness, and company growth among other factors. Please join us in recognizing The Top 100 Healthcare Technology Companies of 2021. Category: Medical Devices Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The company operates through three business segments, including consumer, pharmaceutical and medical devices as well as diagnostics. The medical devices and diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers. These are used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Cordis' circulatory disease management products, DePuy's orthopaedic joint reconstruction, spinal care and sports medicine products and Ethicon's surgical care and women's health products. Johnson & Johnson was founded in 1886 and is now ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Notably, Johnson & Johnson is one of the world's most valuable companies. Earlier this year, Johnson & Johnson revealed that sales of its medical devices climbed 63% year over year, driven by a greater demand for medical devices, drugs and consumer-health products. Category: Medical Devices Integra LifeSciences is a global leader in neurosurgery. The company offers a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management and neuro-critical care. Its regenerative tissue technologies include products that address soft tissue, nerve and tendon repairs and for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery. Founded in 1989 by Richard E. Caruso, the company is headquartered in Princeton, New Jersey. Today, Integra LifeSciences has grown immensely, with over 3000 employees worldwide as well as offices, manufacturing and research facilities in Asia, Australia, Europe, Middle East, and the Americas. Integra products are ubiquitous in many hospital intensive care units and operating rooms around the world. And some of its leading brands include AmnioExcel, Bactiseal, CerebroFlo, Certas Plus, Codman®, CUSA, DuraGen, and DuraSeal. Recently, Integra posted strong second quarter results, with not only better than expected revenue and much better than expected operating earnings. This year the company has shown a strong recovery from the pandemic, with revenues rising almost 49% year over year in the quarter. Category: Healthcare Software SOC Telemed is headquartered in Reston, Virginia, and is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC’s technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care.SOC clients include 18 of the 25 largest health systems in the nation, and its enabled over 1,000 facilities in 47 states to manage complex, acute workflows and provide life-saving care. The company provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health.The company was the first provider of acute clinical telemedicine services to earn The Joint Commission’s Gold Seal of Approval and has maintained that accreditation every year since inception. Category: Medical Devices Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products. Founded in 1988, the company has a global network of more than 25 operating companies. However, its acquisitions of companies like Radiometers has seen the company shift towards diagnostics and life sciences. Today, Danaher’s life science portfolio stands at $6.95 billion. At the heart of the company’s success is the Danaher Business System (DBS), a set of tools that enables continuous improvement around lean, growth and leadership, based on the Japanese philosophy of “Kaizen.” Founded in 1969 by brothers Steven M. Rales and Mitchell Rales, the company was named after Danaher Creek, following a fishing trip there. Danaher owns about 40 businesses around the world and  is currently led by President and CEO Tom Joyce. Steven remains the chairman of Danaher, while Mitch is chairman of the company's executive committee. This year, Danaher announced its plan to acquire Aldevron, which manufactures plasmid DNA, mRNA, and proteins for biotechnology and pharmaceutical customers, for $9.6 billion. Category: Medical Devices Fresenius Medical Care is a healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. Founded in 1996 by Eduard Fresenius (1874-1946) who was a German entrepreneur and pharmacist. Today, the German company cares for more than 345,646 patients in its global network of more than 4,000 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It also operates 44 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables. Recently, Fresenius announced an expansion of its national efforts with Cigna to improve health outcomes and lower the cost of care for people living with kidney failure, or end stage renal disease. Cigna and FMCNA started working together in 2017 and this new agreement extends the program through at least 2023. Category: Healthcare Software NextGen Healthcare offers a range of software, services, and analytics solutions to medical and dental group practices. The company develops and sells electronic health record (EHR) software and practice management systems to the healthcare industry. NextGen Healthcare also provides population health, financial management, and clinical solutions for medical and dental practices. NextGen also offers its cloud-based EHR specifically designed for private practices. NextGen Office is a fully integrated practice management solution that includes specialty-specific content, a claims clearinghouse, and an easy-to-use patient portal. It works on any tablet, laptop (Apple or Windows), is touch-screen enabled, compatible with all browsers, and is HIPAA compliant. Founded in 1974 by Bryan Rosenberger and Patrick Cline with one goal – to make medical offices run more efficiently. The company has since grown to have 2,600 employees across the globe with multiple offices including Irvine, California; Horsham, Philadelphia; and Bangalore, India. In addition to highly configurable core clinical and financial capabilities, the company's portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including: population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. Category: Healthcare Software Castle Biosciences is a skin cancer diagnostics company focused on providing physicians and patients with personalized, clinically actionable genomic information enabling more accurate treatment plan decisions. Since its inception, the company has applied emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes. The Company’s DecisionDx family of molecular diagnostic and prognostic tests have the ability to meaningfully impact how cancers are diagnosed and managed Founded in 2008 by Derek Maetzold — the current President and Chief Executive Officer — the Friendswood, Texas-based company has grown immensely. Today Castle has 292 employees and operates out of two locations. The company has also experienced rapid success since its initial public offering in 2019. Notably, Castle’s revenue in 2020 grew over 20% from 2019, despite the COVID-19 pandemic. This year, Castle announced its collaboration with the Melanoma Research Foundation (MRF), a non-profit organization leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy. Category: Medical Devices Boston Scientific is a medical device company with a focus on noninvasive treatment – primarily of cardiovascular, respiratory, neurological, digestive, urological and pelvic conditions. Its first major product was an angioplasty balloon for cardiovascular treatments, introduced in the late-1970s. By 2017, the company had developed more than 13,000 medical products marketed in 100 countries around the world. For decades, Boston Scientific has worked closely with physicians to develop and introduce single-use technologies to advance patient care across various therapeutic areas. The EXALT Model B Bronchoscope is the latest device to join the company's single-use imaging portfolio alongside the EXALT Model D Single-Use Duodenoscope, LithoVue Digital Flexible Ureteroscope, SpyGlass DS Direct Visualization System and SpyGlass Discover Digital Catheter. The Marlborough, Massachusetts-based company was founded in 1979 by John Abele and Pete M. Nicholas who wanted to make steerable catheters used in less-invasive medical procedures. Boston Scientific went public in 1992. Today the company has grown tremendously, with over 30,000 employees and 15 offices around the US, including Washington DC, San Diego, Boston and Cambridge. Category: Communication Technology The mission of Vocera Communications is to improve the lives of healthcare professionals, patients, and families. Founded in 2000, Vocera provides solutions that help protect and connect team members, simplify workflows, increase efficiency, enhance quality of care and safety, and humanize the healthcare experience. More than 2,300 facilities worldwide, including nearly 1,900 hospitals and healthcare facilities, have selected Vocera solutions to enable their workforce to communicate and collaborate with coworkers and engage with patients and families. Mobile workers can choose the right device for their role or task, including smartphones or one of the company’s wearable communication devices, and use voice commands to easily reach people by name, role, or group. The Vocera Platform can integrate with more than 150 clinical and operational systems, including electronic health records, nurse call systems, ventilators, physiological monitors, and more. In addition to healthcare, Vocera solutions are found in aged care facilities, veterinary hospitals, schools, luxury hotels, retail stores, power facilities, and more. Category: Biotech Poseida Therapeutics, is a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure. Poseida’s game-changing technologies are advancing the promise of cell and gene therapy to deliver potential single-treatment cures. The company is developing a deep and growing pipeline based on its core proprietary platforms, including its non-viral piggyBac® DNA Modification System, Cas-CLOVER™ site-specific gene editing system and nanoparticle-and AAV-based gene delivery technologies. Founded in 2014, the San Diego-based company has grown to 225 employees and is led by CEO Eric Ostertag, M.D., Ph.D., a pioneer in cell and gene therapy and the first graduate of the Gene Therapy Program at the University of Pennsylvania School of Medicine. Poseida’s platform technologies offer unmatched efficiency in gene delivery, fully integrated non-viral genome insertion and precise editing. The company’s CAR-T product candidates modify the immune system’s T-cells to treat multiple myeloma, prostate cancer and other solid tumors like breast, ovarian, colorectal or pancreatic cancers. Poseida also has several liver-directed gene therapy programs focused on the in vivo treatment of rare genetic conditions with high unmet medical need, including ornithine transcarbamylase (OTC) deficiency and hemophilia A. Category: Biotech PPD is a global contract research organization that offers drug development, laboratory, and lifecycle management services. PPD applies innovative technologies, therapeutic expertise, and a firm commitment to quality to help customers bend the cost and time curve of drug development to provide life-changing therapies that improve health. Their clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. Founded in 1985 by Fred Eshelman, the Wilmington, North Carolina-based company has over 27,000 employees. In 2020, PPD issued its initial public stock offering and began trading on the Nasdaq Global Select Market under the symbol PPD. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. In mid-April, laboratory technology specialist Thermo Fisher Scientific announced its acquisition of global contract research organization PPD in a deal valued at $17.4 billion. Category: Healthcare Software GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. The company uses the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges with Galleri. Galleri is GRAIL’s groundbreaking multi-cancer early detection blood test that can detect more than 50 types of cancer, over 45 of which lack recommended screening tests today. Galleri is available in the US. The company was founded in 2016 by Alex Aravanis and Jeff Hub and has raised over $2 billion in funding over five rounds. GRAIL has more than 700 employees and is headquartered in Menlo Park, California, with locations in Washington, DC, North Carolina, and the United Kingdom. It is backed by the likes of Bill Gates and Jeff Bezos, and supported by leading global investors and pharmaceutical, technology, and healthcare companies. GRAIL is currently developing tools to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. Recently, Illumina announced that it’s looking to acquire GRAIL for $7.1 billion, a deal which is yet to be finalized. Category: ​​Medical Devices Bellevue, Washington-based company, Bardy Diagnostics, is an innovator in digital health and remote patient monitoring, with a focus on providing the most diagnostically accurate and patient-friendly cardiac patch monitors to the industry. The company’s CAM patch is a non-invasive, P-wave centric, ambulatory cardiac monitor and arrhythmia detection device that’s designed to improve patient compliance for adults and children. Designed to be worn comfortably and discreetly for up to 14 days, the hourglass-shaped CAM patch is designed for all types of bodies and for optimum ECG signal collection. The company was founded in 2013, by Gust H. Bardy, a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation. He has been a researcher and clinician in the field of sudden death and disabling cardiac rhythm disorders for 38 years with over 400 peer-reviewed publications. With nearly 300 employees working towards saving patient lives, the company’s next step is to distribute a CE-marked 14-day CAM patch outside of the United States. This is one step closer to its P-wave centric detection and analysis technology becoming the global standard of care in long-term cardiac monitoring. Category: Medical Devices 3M Health Care is a global leader that offers medical, dental and orthodontic solutions, health information, food safety and drug delivery systems. The company uses 3M technology as well as its world-class manufacturing and global reach to provide trusted products that help promote health and improve the quality, cost and outcomes of care. While 3M was founded in 1902 with the goal to mine for corundum, a mineral used for making sandpaper and grinding wheels, the company has changed a lot since then. In 1960, the company unveiled its Micropore Surgical Tape, the first hypoallergenic tape on the market. This went on to eventually be the key to its Health Care sector’s success. 3M is led by CEO Mike Roman, with Mojdeh Poul, leading as group president of 3M Health Care. This year, 3M’s healthcare segment reported $2.3 billion in revenues, which is a 24.9% increase from the second quarter of 2020. Sales in the segment increased in oral care, food safety, medical solutions, separation and purification and health information systems, with growth across all geographic areas. Category: Healthcare Software Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience. The company’s mission is to empower us all to easily and affordably pursue the care we need. At a time when consumer-friendly, digital-first experiences are more critical than ever in healthcare, Cedar’s financial technology platform is equipped with modern intelligence to solve many of the fundamental problems that lead to poor consumer financial experiences and administrative waste in healthcare. Cedar clients consistently see strong performance—typically a 30% lift in patient payments—with 88% patient satisfaction. Cedar was founded in 2016 by Arel Lidow, Florian Otto, and Kareem Zaki and is headquartered in New York City. Today, the company engages with more than 300,000 consumers a day, and partners with more than 50 healthcare providers and payers across the US including Yale New Haven Health (YNHHS), Summit Health, Novant Health, ChristianaCare, Blue Cross Blue Shield of Arizona, CommonSpirit Health and Blue Cross Blue Shield of Massachusetts. Over the last two years, the company has undergone a period of tremendous growth, including raising over $300 million in funding, acquiring OODA Health and being named a top place to work. Category: Healthcare Software From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 2.6 million scans in more than 1,800 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money. Founded in 2012 and based in San Mateo, California, RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. The company has seen monumental growth with nearly 1 million scans processed from over 500,000 patients around the world in the first half of 2021 alone. Within this timeframe the company has also introduced new products, including Rapid Workflow for PE, a mobile and web-based app designed to align hospital teams treating patients with suspected pulmonary embolisms. RapidAI also developed RapidforPrehospital, which helps EMS teams and hospitals collaborate to strengthen patient care through a standardized stroke protocol that streamlines data collection. Category: Medical Devices HillRom is an American company focused on medical technologies for the healthcare industry. The company’s product portfolio includes patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products, and information technology solutions. Our innovations in five core areas – Advancing Mobility, Wound Care and Prevention, Patient Monitoring and Diagnostics, Surgical Safety and Efficiency, and Respiratory Health – improve clinical and economic outcomes and ensure caregivers in more than 100 countries have the products they need to protect patients, speed up recoveries and manage conditions. Founded in 1929 by William Noah Allyn, the Batesville, Indiana-based company traces its medical innovation roots to when Dr. Francis Welch and Allyn developed the world's first handheld, direct illuminating ophthalmoscope. In 2020, HillRom adapted its respiratory health device MetaNeb to help treat COVID-19 patients. MetaNeb is typically used on patients with pneumonia and attaches to a ventilator and helps to clear the lungs from mucus secretions. In April 2020, Atlanta’s Emory University reported the successful use of MetaNeb with coronavirus patients on ventilators. Category: Medical Devices PartsSource is the leading B2B marketplace for medtech replacement parts and services. Based in Cleveland, Ohio, the company provides an integrated suite of cloud software and marketplace technology tools to help hospitals efficiently source on-demand parts and services, and empowers vendors to grow their businesses. The company’s technology-based solutions help hospitals increase the uptime of mission critical equipment, improve patient safety, and maximize throughput and profitability. The PartsSource flagship solution, PartsSource Pro, is the only clinical resource management platform for health system enterprises designed to increase the availability and quality of patient care through evidence-based decision support for medical equipment maintenance and purchasing. PartsSource’s evidence-based marketplace connects more than 3,500 hospitals, and 15,000 clinics, with more than 6,000 medtech OEMsand suppliers and 2,000 medtech repair professionals across the country in a single integrated network. The company was founded in 2001, based on the idea that an evidence-based, digital approach to the healthcare supply chain can unlock better healthcare delivery, lower costs, and enhance clinical outcomes.Today, PartsSource is transforming and modernizing healthcare technology supply chains to achieve financial and operational goals. Category: Healthcare Software ImagineSoftware is the leading provider of medical billing automation software and revenue cycle management applications. The company offers powerful technology solutions for practices, billing companies, and hospitals. The first products commercialized by ImagineSoftware included HCFA processing and insurance denial mitigation systems. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately enhance the patient experience across 43 specialties, including radiology, anesthesia, pathology, and emergency medicine. The company was founded in 2000 and is headquartered in Charlotte, North Carolina with additional office locations in California and New York. Today, ImagineSoftware serves more than 75,000 physicians and 47,000 users in all 50 states, the ImagineSoftware product suite boasts $33 billion in charge volume, $800 million in payments processed, and $8.5 billion in collections annually. Always innovating, ImagineSoftware became one of the first in the industry to implement artificial intelligence (AI) within its product suite. ImagineAI, allows health providers to gather detailed patient demographics and payor information while customizing billing messaging based on patients’ ability to pay their medical bills. The system learns and adjusts over time to maximize revenue without compromising compliance. Category: Biotech Immunex is a leading biopharmaceutical company dedicated to developing immune system science to protect human health. Applying our scientific expertise in the field of immunology, cytokine biology, vascular biology, antibody-based therapeutics and small molecule research, we work to discover new targets and new therapeutics for treating rheumatoid arthritis, asthma, and other inflammatory diseases, as well as cancer and cardiovascular diseases. Immunex is best associated with the development of products such as Enbrel, used in the treatment of rheumatoid arthritis; Novantrone, used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine, for use in bone marrow transplant patients. Founded 1981 by James R. Uhlir and Steven Gillis, the company based in Seattle, Washington. In 2002, Immunex Corporation was acquired by Amgen in a mammoth $16 billion deal. At the time, this deal reflected the growing interest in recently developed biotech drugs and the biotech sector overall. Category: Biotech Ardelyx is a biotech company focused on discovering, developing, and commercializing medicines to support patients with kidney and cardiorenal diseases. The company’s molecules are known to target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to help patients. Its lead products include RDX5791, which is being developed both for constipation-predominant irritable bowel syndrome (IBS-C) and for prevention of excess dietary sodium absorption, a new treatment for high blood pressure. Ardelyx was established in 2007 by Dominique Charmot and Peter G. Schultz with the goal to create novel drugs acting in the GI tract with minimal systemic exposure. Today, the Fremont, California-based company has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor — a treatment for patients with chronic kidney disease — in their respective territories. Category: Biotech DNA Script is a pioneering life sciences technology company developing a faster and more versatile way to design and manufacture nucleic acids. The company has developed an alternative to traditional DNA synthesis called enzymatic DNA synthesis (EDS). By putting DNA synthesis back in the lab, DNA Script aims to transform life sciences research through innovative technology that gives researchers unprecedented control and autonomy. Founded in 2015 by Sylvain Gariel, Thomas Ybert, and Xavier Godron, the company is based in Paris, France with an additional office in San Francisco, California. This year, the company has experienced significant traction this year, with the launching of its SYNTAX System in June. Prior to the launch, the SYNTAX System and DNA Script’s EDS technology were selected to collaborate on potentially world-changing advances and visionary projects. DNA Script is collaborating on the development of on-demand therapeutics and diagnostics to address future pandemics through the French Defense Innovation Agency (DGA) as well as through separate partnerships with Moderna and GE Research in support of research grants from the US Defense Advanced Research Projects Agency (DARPA). Category: Biotech Syneos Health is designed to accelerate customer performance to address modern market realities. The company brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together they share insights, use the latest technologies and apply advanced business practices to speed customers’ delivery of important therapies to patients. Syneos (formerly Inventiv Health) was born out of a $7.4 billion merger between INC Research and inVentiv Health in 2018. Inventiv Health was founded in 1996 while INC Research was established in 1985. Today, Syneos is based in Raleigh, North Carolina and remains as the only fully integrated end-to-end clinical and commercial solution organization. This year, Syneos revealed that it has expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, as part of its continuing efforts to move clinical trials closer to the patient. Decentralized Solutions from Syneos Health combines insights, technologies, trial design experience to help transform drug development. It’s a revolutionary way that could effectively reduce redundancies, relieve site burden and create more patient journey-informed trial experiences. Category: Consumer HealthTech IBH has reimagined mental health and EAP services by investing significantly in data science and digital therapeutics. The result is a comprehensive solution that combines on-demand digital resources with live support by expert clinicians backed by first-class technology for an effective mental health program. The company’s proactive, digitally enabled EAP delivers unparalleled access combined with highly personalized care that is precisely customized to each person’s preferences. This approach leads to better program outcomes, a healthier and more productive workforce, and true cost savings for its customers. Founded in 1988, IBH quickly emerged as a trusted behavioral health consultant to large corporations across the nation. Today, the company services more than 38,000 companies, and supports over 8 million people with their mental health. As one company with one vision, IBH provides innovative, technology-based tools and holistic programs that focus on positive outcomes through clinically validated methods and tools. IBH surrounds users with a full system of support by offering EAP counseling, mental health coaching, digital CBT courses, chronic condition management, and work-life, legal and financial services—all accessible through a single, easy-to-use platform. Category: Medical Devices Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients. The company’s proprietary Nano-Pulse Stimulation™(NPS) technology offers a unique cellular-specific mechanism that has extensive utility across several medical specialties. The CellFX System is the company’s first commercial product to harness the distinctive advantages of NPS technology to address a range of common dermatologic conditions that have generally been challenging to treat with traditional methods. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model deployed through a proprietary cloud-based infrastructure. Pulse Biosciences was founded in 2014, born from the groundbreaking research of nano-pulsed technology breakthroughs discovered by leading bioelectric researchers at Old Dominion University and the University of Southern California. The company is headquartered in Hayward, California and to date, Pulse Biosciences holds more than 112 issued licensed patents worldwide. This year, the CellFX System received U.S. FDA clearance, the CE Mark for commercialization in the European Union and a Medical Device License from Health Canada. Category: Biotech Alltech is a global animal health company providing natural, nutritional supplements for livestock and poultry producers. Through its innovative study of nutrigenomics, the company’s nutritional technologies help animals maximize the nutrients in their feed for optimal well-being and performance. Alltech works with producers across the globe to address important animal nutrition issues and helps them to increase their efficiency, productivity and profitability through analytical services. Alltech was founded in 1980 by Dr. Pearse Lyons, who moved to the US in the 70s with a dream to help sustain the planet and all that lived on it. Today, The Nicholasville, Kentucky-based company has amassed a global team of more than 5,000 people who help to improve plant, feed and food quality through nutrition and scientific innovation, particularly yeast-based technology. This year, Alltech launched Acutia, a wholly owned subsidiary of Alltech, which combines science and sustainability to provide high-quality supplements that enhance everyday nutrition and improve long-term wellness. Acutia’s initial line of products will be rolled out in phases, beginning with Acutia Selenium and later Acutia Digestive Health. In 2019, researchers with Alltech Life Sciences achieved a breakthrough that offers a possible alternative to current insulin treatments for those living with diabetes. Category: Biotech BioDelivery Sciences International is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. The company uses their novel and proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. Founded in 1997 and headquartered in, today BioDelivery Sciences has 170 employees. BioDelivery’s marketed products — and those in development — address serious conditions such as breakthrough cancer pain, chronic pain, painful diabetic neuropathy and opioid dependence. It looks to improve upon existing drugs by enhancing their efficacy and ease of administration, or create new therapies, all with the ultimate goal of enhancing patient care. Category: Healthcare Software Qventus is the first real-time operations system for healthcare. Building on formative experiences at Stanford and McKinsey, Qventus was founded in 2012 with the belief that world-class healthcare requires first class operations. Integrating with EHRs, the Qventus real - time automation platform uses AI and behavioral science to power best practice solutions for operational challenges in inpatient, ED, perioperative, and command center settings. To operationalize the software, the Qventus Expert Services helps establish governance, deploy the solutions, and drive change management. With backing from leading investors including Bessemer Venture Partners, Norwest Venture Partners, and the Mayfield Fund, the company is developing a complete system for transforming the operations of health systems and hospitals nationwide. Qventus is a proven partner with hundreds of deployments in community hospitals, academic medical centers, and large health systems across the country, including Bon Secours Mercy Health, CommonSpirit Health, HonorHealth, M Health Fairview, and Saint Luke’ s Health System. With Qventus, these systems have been able to achieve significant and sustained outcomes, including 90% lower excess days per patient. Category: Biotech Biocon Biologics is a fully-integrated pure-play biosimilars organization globally engaged in developing high-quality, affordable biosimilars aimed at expanding patient access to cutting-edge therapies. It develops and commercializes a differentiated portfolio of novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as generic formulations in the US and Europe. Founded 1978 by Kiran Mazumdar-Shaw, the company is driven by a belief that the pharmaceutical industry has a humanitarian responsibility to provide essential drugs to patients who are in need and to do so with the power of innovation. In 1979, just a year after being established, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe Today, Biocon has a large portfolio of biosimilars under global clinical development with three of these commercialized in at least one of the developed markets of Europe, US, and Japan. Biocon Biologics has a product pipeline of 28 molecules, including 11 with Mylan, several with Sandoz and is developing many independently. Category: Healthcare Software PaxeraHealth Corp is a world leading innovative medical imaging solution developer, designing next generation technology to elevate patient care and improve clinical, financial, and operational outcomes. PaxeraHealth has been at the forefront of artificial intelligence (AI) development for the medical imaging industry, utilizing AI technology at the core of their solutions. Founded in 2009, PaxeraHealth has expanded to over 140 employees in 10 countries, with its head office in Boston, Massachusetts and an active dealer network in over 45 countries. This year, the company is launching PaxexaUltima 8th Generation, an artificial intelligence (AI)-based imaging platform. It provides cutting edge AI algorithms to analyze large data sets, prioritize studies, and provide support for clinical analysis. Additionally, the intelligent platform enables healthcare systems to self-develop AI algorithms based on their own data sets. Built from the ground up, the 8th generation AI-based imaging platform offers a viable solution to clinical, economic, and volume-based challenges. The native cutting-edge AI algorithms concurrently aid with analyzing large sets of data, prioritizing high-risk studies, decreasing reading times, and reducing false positives and costly patient recalls. Category: Consumer HealthTech B.well Connected Health offers digital technology for health information and empowers consumers to manage all of their healthcare in one location. The b.well Connected Health platform — which they call the “new front end” of healthcare — can be enabled to collect and aggregate their healthcare data across providers, insurance companies, labs, pharmacies and Medicare, as well as any third-party app, wearable or device, and to share it with whomever they choose. It specializes and supports health plans, health systems, employers and pharmaceutical companies. The company was founded by Bryan Jones and Kristen Valdes in 2015 and is headquartered in Baltimore, Maryland. Since then, the company has grown significantly and is contracted to support over 7 million people. This year, b.well Connected Health announced it had raised an oversubscribed financing round. The funding round followed a strong year of growth in 2020–21, which saw business double as more organizations implemented the b.well platform to connect with their patients, employees and communities. Category: Biotech Cerexa is a biopharmaceutical company that produces a portfolio of anti-infective therapies for the treatment of life-threatening infections. The company’s product portfolio includes Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens. Founded in 2005 by Dennis Podlesak and James Ge, Cerexa was a spin-out from Peninsula Pharmaceuticals and went on to become acquired by Forest Laboratories in 2007 for $500 million. Forest was later acquired by Allergan (formerly Actavis) in 2014. Allergan, is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential to see more clearly, move more freely, express themselves more fully. Founded in 1950 by pharmacist Gavin S. Herbert Allergan focused on the discovery and development of novel formulations for specialty markets, as well as intimate collaboration with physicians and the scientific community. Category: Biotech Genuity Science is a biotechnology company that uses leading genomics and machine learning to map the causal biology of disease and accelerate the development of better medicine. Genuity partners with global biopharma companies to offer deep end-to-end discovery services aimed at catalyzing precision health and improving the quality of life for patients around the world. Its services include population-scale, disease-specific data sourcing, high-quality sequencing, robust statistical analysis and software tools for analyzing large datasets and artificial intelligence (AI). Founded in 2013 and headquartered in Boston, Massachusetts, Genuity has grown to have more than 1000 employees. This includes over 70 experts in molecular biology, population genomics, oncology, neurology, computational and systems biology, clinical genetics, AI and machine learning. This year, Genuity Science launched the Genuity AI Research Institute (GAIRI), a collaborative research and development platform. GAIRI is led by Chief Technology Officer, President and Founding Director Tom Chittenden, Director of Computational Biology Tiago Magalhaes, Director of Computational Statistics Jose Malagon Lopez, and Director of Bioinformatics Allison McLean. GAIRI is designed to accelerate the development and application of AI and machine learning solutions to medicine and healthcare. Category: Healthcare Software AKASA is an AI-powered automation company for revenue cycle management in healthcare. The company is propelled by its mission that “every dollar spent on healthcare matters because healthcare matters to everyone.” Motivated to demystify the complexity of American healthcare, AKASA enables health systems to decrease their cost to collect so they can invest more in patient care and better invest in providing healthcare using the same machine learning approaches that made driverless cars possible. Founded in 2018 by Andy Atwal, Benjamin Beadle-Ryby, Malinka Walaliyadde and Varun Ganapathi, the San Francisco company is led by pioneering Silicon Valley leaders who have founded or been founding team members of multiple companies with successful exits. The company also includes senior leaders in healthcare as well as a deep well of talent from healthcare services firms like the Advisory Board, Optum and Triage Consulting. This year, AKASA announced that it had raised a funding round, tripling its prior round in 2020. The company plans to use the funding to invest in talent, scale operations to meet rapidly growing customer demand, and continue to accelerate delivery of products to customers. Its investors include Andreessen Horowitz, BOND and Costanoa Ventures. Category: Biotech ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care. The company is focused on developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. ImClone's research and clinical development capabilities are augmented by its expertise in the scale-up and manufacturing of biologics. The company's state-of-the-art FDA-approved manufacturing facilities in Branchburg, New Jersey, provide it with one of the largest biologic manufacturing capacities in the world. Founded in 1984 by Samuel D. Waksal, the company was acquired by Eli Lilly and Company in 2008 and became a fully-owned subsidiary of Eli Lilly and Company. Following its acquisition by Eli Lilly and Company in 2008, ImClone Systems is accelerating its antibody pipeline development by leveraging Lilly's global capabilities. ImClone's pipeline has several molecules in mid- to late-stage clinical development targeting virtually all major solid tumor types. Additionally, ImClone plans to advance several additional targets from its research programs into clinical development over the coming years. Category: Consumer HealthTech Neptune Wellness Solutions is a health and wellness company focused on extraction, formulation, and packaging of legal cannabis products. The company specializes in three main areas of cannabis and industrial hemp extraction, turnkey solutions, and consumer brands. Its current manufacturing includes natural products in the pet supplement, nutrition, hemp,and krill oil industries. With its scientific and technological expertise, Neptune aims to redefine health and wellness through social responsibility, sustainability, and innovation for all generations. Founded in 1998 by Henri Harland, the formerly Quebec, Canada-based company recently moved its headquarters to South Florida. The company is currently led by Michael Cammarata, who grew up in Florida, and is the co-founder and former CEO of Schmidt’s Naturals, which he sold to Unilever for an undisclosed amount in 2017. Today, Neptune’s brands include Biodroga Nutraceuticals, MaxSimil, Organic Foods & Beverages, Beauty & Personal Care, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, NurturMe, and Nosh. Under the Forest Remedies brand, Neptune offers a full line of health and wellness products with and without cannabidiol. Category: Biotech Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related gastrointestinal (GI) disorders. The company is pushing the limits of what’s possible to awaken a dormant category that has lacked innovation for nearly 30 years working to usher in a new era of treatment for the millions of underserved patients suffering from acid-related disorders. Phathom has licensed the exclusive rights in the U.S., Europe, and Canada to vonoprazan, a potassium competitive acid blocker (P-CAB) in late clinical-stage development for the treatment of gastric acid-related disease. Vonoprazan has the potential to be a paradigm shift in GI treatment and the first gastric antisecretory agent from a new class approved in the U.S., Europe, or Canada in over 25 years. Phathom’s IPO was completed in October 2019 and currently has a market cap of over $1 billion. Despite the global pandemic, Phathom skillfully navigated uncertain circumstances to safely continue its global clinical trials. Category: Biotech Meda Biotech is a clinical-stage biopharmaceutical company developing a new class of hybrid water-soluble drugs. These drugs have unprecedented control over its properties to maximise delivery to disease sites, dramatically enhancing efficacy while minimising toxicities. Meda also develops Hybrid water soluble drugs in collaboration with pharmaceutical and biotechnology partners to enable promising pipeline candidates to achieve their full potential. Founded in 2003, Media is composed of researchers who are extremely eager to discover and develop additional game changing therapeutics. The company has been working to commercialise a technology that could make treatment more effective and less harmful to patients, especially for the treatment of cancer, pain and inflammation. Meda Biotech is developing a pipeline of novel hybrid drugs that hold the potential to become best-in-class drugs and improve patient outcomes in the areas of oncology, inflammatory diseases and cardiovascular and GI disorders. Meda's lead product candidate, Mewa001 (Aspirin) is currently in Phase 1 clinical testing in cancer patients for pain and inflammation. Category: Consumer HealthTech Vesta Healthcare’s unique “Homecareist” model offers an integrated, patient and caregiver centered program that connects caregiver insights, technology tools and telehealth services all under the supervision of a virtual physician group - all with the aim of enabling their members to have more healthy days at home. Using Remote Patient Monitoring devices, Personal Emergency Response Systems (PERS), a proprietary mobile app and other technologies, Vesta captures real - time insights from home - based caregivers. As insights are gathered, Vesta’s team of clinicians provide 24/7 support by providing virtual care, mobilizing appropriate clinical intervention, educating paid and unpaid caregivers, and coordinating follow - up care with physicians and care managers. In addition to improved quality metrics, reductions in total costs of care, and tighter integration of healthcare and SDoH needs, Vesta’s programs have reduced Emergency Room visits and Hospital Admissions by over 30% and enabled 94% of follow - up care for its members to be delivered in the community rather than a facility. Vesta Healthcare was founded in New York, NY in 2018, with investment from Oak HC/FT, Deerfield Management, Optum Ventures, Kaiser Permanente Ventures, Lux Capital, Generator Venture s and Nationwide Ventures. With over 50 different Health Plan, Home Care Agency and Provider partners, Vesta currently serves over 50,000 members through its programs. Category: Medical Devices Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician's office. The company was founded in 2016 by Amit Vohra, Michael Bartholomew, and developed by a team of entrepreneurs and healthcare innovators into a minimally invasive and patient centric MRI and robotic platform. Based in Oakland, California, and backed by over 90 patents, the company’s mission is to improve lives through state of the  art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. Recently, the Company received 510(k) clearance from the U.S. FDA for its revolutionary office - based MRI system, allowing practices and hospitals to seamlessly guide prostate interventions under the single - sided scanner. Promaxo has formed numerous long-term and strategic partnerships with investor groups and corporations as it prepares to enter the US market. Category: Biotech Pall Corporation is a global leader in high-tech filtration, separation, and purification, serving the diverse needs of customers across a wide range of applications. The company provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines, cell therapies and classic pharmaceuticals. Pall offers advanced medical technologies, which are often a patient’s last line of defense from dangerous pathogens. Pall’s food and beverage products provide critical protection from contaminants during various manufacturing steps. Founded in 1946, Pall has a strong track record of innovation and performance. Since joining Danaher, Pall has continued to drive innovation, developing everything from a mobile water treatment portfolio to an advanced filtration membrane for wet chemical processing. This year, Cytiva and Pall — both of which are part of Danaher — said they’ll expand manufacturing capacity and services across geographies for global life sciences customers. The $1.5 billion two-year investment is already underway. The deal includes new sites, expansion at existing factories, and is in addition to previously announced investments. Category: Consumer HealthTech Mixlab is a modern, pet pharmacy, based in New York and Los Angeles, that partners with veterinarians to make their jobs easier and deliver the highest level of care to pet parents. The company was built upon three core values —#makeithappen, #dowhatsright and #mixedwithlove. The Mixlab team does everything that it takes to deliver the best personalized care to pets, in the fastest and most humane way possible. Mixlab’s technology includes a platform that manages the home delivery of medications across branded, generic and over-the-counter medications, which helps to reduce a clinic’s on-site pharmaceutical inventory. Veterinarians can write prescriptions in seconds and track medication progress and therapy compliance. Mixlab was founded in 2017, by Fred Dijols and Stella Kim with the goal to provide a better pharmacy experience, with the veterinarian at the center. Dijols’ background is in medical devices as well as healthcare investment banking, where he became interested in the pharmacy industry, following TruePill and PillPack. Category: Medical Devices Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. The company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Notably, Edwards developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, which was FDA-approved for the treatment of patients at low risk for death or major complications associated with open-heart surgery in 2019. Edwards was founded by engineer Miles “Lowell” Edwards in 1958. Today, the Irvine, California-based company has over 3000 employees, with additional offices located in Utah and Singapore as well as numerous commercial operations across the globe. This year, Edwards announced that it has established a Social Impact Investment Fund to advance racial equity in healthcare. The $100 million fund is a portfolio of investments aimed at advancing racial equity through economic development in Black and underserved communities in the US. It has already committed $70 million of its $100 million fund to provide additional capital for targeted programs, economic initiatives and community development projects. Category: Medical Devices SleepHive, formerly Revitalife, is an industry leading medical devices company specializing in high performance sleep. The company produces a premium range of therapeutic products for everyone from elite athletes to people over the age of 60. There’s a focus on innovative technology SleepHive looks to shape the waking lives of our customers by shaping their resting lives. SleepHive is an Australian family-owned and operated class 1 medical devices company specialising in innovative therapeutic products for everyone, from elite athletes to senior Australians. As a registered National Disability Insurance Scheme (NDIS) provider SleepHive works closely with leading health and medical professionals, with the mission to help more Australians suffer less, enjoy faster recovery and attain restful sleep. With distribution centres in Sydney, Melbourne, Adelaide and Perth, and a head office and showroom on the Gold Coast, the "therapeutic sleep systems" manufacturer SleepHive is a big operation. SleepHive offers one-on-one personalised consultations, both in-home and online, to work with customers in building a sleep solution that works best for their unique needs and requirements. Category: Biotech Illumina is a biotech company focused on applying innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. Illumina was founded in San Diego, California in 1998 by David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel. By 2014, the company claimed its technology had reduced the cost of sequencing a human genome to US$1,000, down from a price of $1 million in 2007. Recently, Illumina’s CEO Francis deSouza revealed that a 78% increase in second-quarter sales over 2020 “significantly exceeded expectations.” That amounts to $1.13 billion in revenue, resulting from DNA-based cancer screening and population genomics testing efforts returning to business as usual, as well as the company’s COVID-19 surveillance programs, which use genetic sequencing to trace the spread of new variants. Category: Medical Devices ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. ResMed was founded in 1989 by Michael Farrell and is headquartered in San Diego, California. Its team of over 8,000 employees makes a positive impact on millions of lives every day in more than 140 countries. The company has a goal to change the lives of 250 million people by 2025. This year, ResMed announced the release of the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. ResMed is launching the AirSense 11 starting in the U.S., and expects to add more locations. It is compatible with all of the company’s existing masks, according to the announcement. Category: Biotech QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is a pioneer in Precision Medicine and the global leader in collaborations with pharmaceutical and biotechnology companies to co-develop companion diagnostics, which detect clinically relevant genetic abnormalities to provide insights that guide clinical decision-making in diseases such as cancer. Its sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. Founded in 1984 by Metin Colpan, Karsten Henco, Jürgen Schumacher, the company now employs more than 5,900 people in over 35 locations worldwide. QIAGEN serves more than 500,000 customers around the globe. This year, QIAGEN received emergency use authorization from the FDA for its QIAreach® SARS CoV-2 Antigen Test, which is designed for environments that require a high volume of fast and accurate test results. Category: Medical Devices Carestream Health is a worldwide imaging company. The company provides digital X-ray products and X-ray film for the medical and non-destructive testing market worldwide. It also provides product, technical, and service support, including remote equipment and software management services. Today, Carestream owns over 600 patents in digital imaging, film, and imaging chemistry. Carestream was established in 2007 when Onex Corporation purchased Eastman Kodak's Health Group. Today, the company employs around 4,500 people who serve a global customer base. Carestream is headquartered in Rochester, New York, with locations around the world, including Shanghai, Hong Kong and Mumbai. This year, the company announced it had begun investigating the use of  NVIDIA Clara AGX — an embedded AI platform for medical devices — in the development of AI-powered features on single-frame and streaming x-ray applications. Carestream is creating smart X-ray rooms that will include AI-powered features for an enhanced imaging workflow and faster, more efficient exams. The devices include automated positioning and exposure settings for similar exam types, which helps improve the consistency of X-ray images, boosting diagnostic confidence. Category: Healthcare Software Meditech empowers healthcare organizations to keep their patients and their business healthy. The company has driven EHR innovation during every stage of the industry's evolution. Today it helps healthcare organizations around the world with MEDITECH Expanse, a web-based EHR that’s setting new standards for usability, efficiency, and clinician satisfaction. Its software is used in almost every healthcare setting, from acute centers and ambulatory practices, to home health and hospice, long-term care facilities, patients’ homes and beyond. Headquartered in Westwood, Massachusetts, the company was founded in 1969 when co-founder Neil Pappalardo began development of the programming language MIIS. This was one of several proprietary implementations of MUMPS, a programming language which at the time had not been standardized. In that same year, Pappalardo and Morton E. Ruderman, Curtis W. Marble, Jerome H. Grossman and Edward B. Roberts founded the company. Today, Meditech’s software is used by a quarter of all hospitals in the U.S., nearly half of all Canadian hospitals, and healthcare organizations in 23 countries. More recently, Meditech launched Expanse Patient Care, a web-based application software that allows nurses and therapists to conduct administrative tasks through a mobile device. Category: Healthcare Software Omnicell is a leading provider of automated and business information solutions enabling hospitals and healthcare. The company is focused on transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom use Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. Omnicell was founded in 1992 by Randall A. Lipps after his daughter was hospitalized at birth and he observed nurses had difficulty locating medical supplies. With the help of graduate students from Stanford University, he developed a prototype of a system that automated inventory management tasks performed manually by nurses. Recently, the company announced it is set to acquire pharmacy software solutions provider, FDS Amplicare for $177 million. Category: Healthcare Software Medidata Solutions offers SaaS-based clinical development solutions addressing the functioning of customers' clinical trials. The company helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Medidata and contract research organizations exist to connect pharmaceutical companies with the doctors and nurses who run the trials on the ground. Founded in 1999, Medidata is headquartered in New York City and has offices around the world, including Boston, Houston, San Francisco, Beijing, Tokyo, London and Singapore. It made its initial public offering on the Nasdaq Stock Market in 2009. And in 2019, Medidata was acquired by Dassault Systèmes. Today, more than one million registered users spanning customers and partners access its platform for clinical development, commercial, and real-world data. The company has counted Novartis and Tesaro as clients, among other large and small pharmaceutical companies and biotechs. Medidata's cloud platform was used in the clinical trials for Moderna's COVID-19 vaccine. Category: Biotech In 2010, Adamed Group was founded, consisting of: Adamed, Pabianickie Zakłady Farmaceutyczne Polfa and Adamed Consumer Healthcare among others. Adamed Pharma is a pharmaceutical and biotechnological company, founded on the basis of its own scientific advances and a patent portfolio. With a dedicated team of over 2200 employees, Adamed engages in the development, licensing, manufacturing, marketing and distribution of pharmaceuticals and consumer health products into Europe, MENA, Australia and the Pacific region - more than 70 countries globally, the references include the most renowned pharma corporations. As a company established and still run by medical doctors, Ada

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

inVentiv Health Patents

inVentiv Health has filed 4 patents.

The 3 most popular patent topics include:

  • Abandoned drugs
  • Amines
  • Computer printing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/29/2016

8/8/2017

Digital press, Computer printing, Amines, Abandoned drugs, Network protocols

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/29/2016

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/8/2017

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Digital press, Computer printing, Amines, Abandoned drugs, Network protocols

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.